In one of these patients, antibody detection lead to the discovery of ovarian cancer, suggesting ARHGAP26 autoantibodies as a potential marker of a paraneoplastic neurological syndrome (PNS). This evidence concerns the gene ARHGAP26 and paraneoplastic neurologic syndrome.